Temat: "screening" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Current Updates on Expanded Carrier Screening: New Insights in the Omics Era.
Autorzy :: Veneruso I; Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Via Sergio Pansini 5, 80131 Naples, Italy.; CEINGE-Biotecnologie Avanzate, Via G. Salvatore 486, 80145 Naples, Italy.
Di Resta C; Università Vita-Salute San Raffaele, Via Olgettina 58, 20132 Milan, Italy.
Tomaiuolo R; Università Vita-Salute San Raffaele, Via Olgettina 58, 20132 Milan, Italy.
D'Argenio V; CEINGE-Biotecnologie Avanzate, Via G. Salvatore 486, 80145 Naples, Italy.; Department of Human Sciences and Quality of Life Promotion, San Raffaele Open University, Via di Val Cannuta 247, 00166 Rome, Italy.; Pokaż więcej
Źródło :: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2022 Mar 21; Vol. 58 (3). Date of Electronic Publication: 2022 Mar 21.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Genetic Counseling*
Mass Screening*
Child ; Ethnicity ; Genetic Carrier Screening/methods ; Humans ; Infant, Newborn ; Mutation
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Opioids, Vision Screening, Altered Mental Status, Hemochromatosis, Osteomyelitis, Renal Disease.
Źródło :: American family physician [Am Fam Physician] 2022 Apr 01; Vol. 105 (4), pp. 362.
Typ publikacji :: Journal Article
MeSH Terms :: Hemochromatosis*/diagnosis
Osteomyelitis*/diagnosis
Osteomyelitis*/drug therapy
Vision Screening*
Analgesics, Opioid ; Genetic Testing ; Hemochromatosis Protein ; Histocompatibility Antigens Class I/genetics ; Humans ; Mass Screening
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Development and use of the Australian reproductive genetic carrier screening decision aid.
Autorzy :: King E; Australian Genomics Health Alliance, Melbourne, VIC, Australia.; Genomics in Society, Murdoch Children's Research Institute, Melbourne, VIC, Australia.; Department of Paediatrics, The University of Melbourne, Melbourne, VIC, Australia.; Bruce Lefroy Centre for Genetic Health, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Halliday J; Department of Paediatrics, The University of Melbourne, Melbourne, VIC, Australia.; Reproductive Epidemiology, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Archibald AD; Department of Paediatrics, The University of Melbourne, Melbourne, VIC, Australia.; Victorian Clinical Genetics Services, The Royal Children's Hospital, Melbourne, VIC, Australia.
Delatycki M; Department of Paediatrics, The University of Melbourne, Melbourne, VIC, Australia.; Bruce Lefroy Centre for Genetic Health, Murdoch Children's Research Institute, Melbourne, VIC, Australia.; Victorian Clinical Genetics Services, The Royal Children's Hospital, Melbourne, VIC, Australia.
Barlow-Stewart K; Northern Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Newson AJ; Australian Genomics Health Alliance, Melbourne, VIC, Australia.; Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, University of Sydney, Sydney, NSW, Australia.
McClaren BJ; Australian Genomics Health Alliance, Melbourne, VIC, Australia. .; Genomics in Society, Murdoch Children's Research Institute, Melbourne, VIC, Australia. .; Department of Paediatrics, The University of Melbourne, Melbourne, VIC, Australia. .; Bruce Lefroy Centre for Genetic Health, Murdoch Children's Research Institute, Melbourne, VIC, Australia. .; Pokaż więcej
Źródło :: European journal of human genetics : EJHG [Eur J Hum Genet] 2022 Feb; Vol. 30 (2), pp. 194-202. Date of Electronic Publication: 2021 Nov 01.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Decision Support Techniques*
Mass Screening*
Australia ; Decision Making ; Female ; Genetic Carrier Screening ; Humans ; Pilot Projects ; Pregnancy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Using the in vitro drug sensitivity test to identify candidate treatments for transient abnormal myelopoiesis.
Autorzy :: Yokosuka T; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Ito M; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Yoshino Y; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Hirose A; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Nakamura W; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Sakurai Y; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Hayashi A; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Fujita S; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Miyagawa N; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Keino D; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Iwasaki F; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Hamanoue S; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Yanagimachi M; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Goto S; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Nagai JI; Department of Laboratory Medicine, Kanagawa Children's Medical Center, Yokohama, Japan.
Ueno H; Department of Pediatrics, Kyoto University Hospital, Kyoto, Japan.
Takita J; Department of Pediatrics, Kyoto University Hospital, Kyoto, Japan.
Tanaka Y; Department of Pathology, Kanagawa Children's Medical Center, Yokohama, Japan.
Taga T; Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.
Goto H; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.; Pokaż więcej
Źródło :: British journal of haematology [Br J Haematol] 2022 Feb; Vol. 196 (3), pp. 764-768. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Drug Screening Assays, Antitumor*/methods
Antineoplastic Agents/*pharmacology
Leukemoid Reaction/*drug therapy
Myelopoiesis/*drug effects
Adult ; Antineoplastic Agents/therapeutic use ; Biomarkers ; Cell Culture Techniques ; Cells, Cultured ; Female ; Gene Expression Regulation/drug effects ; High-Throughput Nucleotide Sequencing ; High-Throughput Screening Assays ; Humans ; Immunohistochemistry ; Leukemoid Reaction/etiology ; Leukocytes, Mononuclear/drug effects ; Male ; Middle Aged
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Response to comment on: Red reflex test screening for neonates: A systematic review and meta-analysis.
Autorzy :: Taksande A; Department of Pediatrics, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Sawangi Meghe, Wardha, Maharashtra, India.
Jameel PZ; Department of Pediatrics, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Sawangi Meghe, Wardha, Maharashtra, India.; Pokaż więcej
Źródło :: Indian journal of ophthalmology [Indian J Ophthalmol] 2022 Jan; Vol. 70 (1), pp. 332.
Typ publikacji :: Letter; Comment
MeSH Terms :: Vision Screening*
Humans ; Infant, Newborn ; Neonatal Screening ; Physical Examination ; Reflex
: Opinia redakcyjna

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 6 6.

Tytuł :: Comment on: Red reflex test screening for neonates: A systematic review and meta-analysis.
Autorzy :: Tariq MA; Department of Ophthalmology, Dow University Hospital, Dow International Medical College, Karachi, Pakistan.
Mohiuddin A; Department of Ophthalmology, Dow University Hospital, Dow International Medical College, Karachi, Pakistan.; Pokaż więcej
Źródło :: Indian journal of ophthalmology [Indian J Ophthalmol] 2022 Jan; Vol. 70 (1), pp. 331-332.
Typ publikacji :: Letter; Comment
MeSH Terms :: Vision Screening*
Humans ; Infant, Newborn ; Mass Screening ; Physical Examination ; Reflex
: Opinia redakcyjna

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 7 7.

Tytuł :: Improving the Speed and Selectivity of Newborn Screening Using Ion Mobility Spectrometry-Mass Spectrometry.
Autorzy :: Dodds JN; Department of Chemistry, North Carolina State University, Raleigh, North Carolina 27695, United States.
Baker ES; Department of Chemistry, North Carolina State University, Raleigh, North Carolina 27695, United States.; Pokaż więcej
Źródło :: Analytical chemistry [Anal Chem] 2021 Dec 28; Vol. 93 (51), pp. 17094-17102. Date of Electronic Publication: 2021 Dec 01.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :: Ion Mobility Spectrometry*
Neonatal Screening*
Biomarkers ; High-Throughput Screening Assays ; Humans ; Infant, Newborn ; Mass Spectrometry
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Does Direct-to-Consumer Personal Genetic Testing Improve Gynecological Cancer Screening Uptake among Never-Screened Attendees? A Randomized Controlled Study.
Autorzy :: Watanabe M; Department of Public Health, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
Hosono S; Department of Public Health, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.; Division of Cancer Screening Assessment and Management, Institute for Cancer Control, National Cancer Center, Tokyo 104-0045, Japan.
Nakagawa-Senda H; Department of Public Health, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
Yamamoto S; Health Promotion Division, Okazaki City Public Health Center, Okazaki 444-8545, Japan.
Aoyama M; Health Promotion Division, Okazaki City Public Health Center, Okazaki 444-8545, Japan.
Hattori S; Okazaki City Public Health Center, Okazaki 444-8545, Japan.
Yamada T; Okazaki City Medical Association, Public Health Center, Okazaki 444-0875, Japan.
Suzuki S; Department of Public Health, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.; Pokaż więcej
Źródło :: International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Nov 24; Vol. 18 (23). Date of Electronic Publication: 2021 Nov 24.
Typ publikacji :: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :: Direct-To-Consumer Screening and Testing*
Uterine Cervical Neoplasms*
Early Detection of Cancer ; Female ; Genetic Testing ; Humans ; Mass Screening ; Middle Aged
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Assessment of hearing screening programmes across 47 countries or regions III: provision of childhood hearing screening after the newborn period.
Autorzy :: Bussé AML; Department of Otorhinolaryngology and Head, Neck Surgery and Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Mackey AR; CLINTEC, Karolinska Institutet, Stockholm, Sweden.
Carr G; Early Hearing Detection, Intervention and Family Centered Practice, London, UK.
Hoeve HLJ; Department of Otorhinolaryngology and Head, Neck Surgery and Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Uhlén IM; CLINTEC, Karolinska Institutet, Stockholm, Sweden.
Goedegebure A; Department of Otorhinolaryngology and Head, Neck Surgery and Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Simonsz HJ; Department of Otorhinolaryngology and Head, Neck Surgery and Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Pokaż więcej
Corporate Authors :: EUS€REEN Foundation
Źródło :: International journal of audiology [Int J Audiol] 2021 Nov; Vol. 60 (11), pp. 841-848. Date of Electronic Publication: 2021 Apr 09.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Hearing Tests*
Mass Screening*
Audiometry, Pure-Tone ; Child, Preschool ; Hearing ; Humans ; Infant, Newborn ; Neonatal Screening ; Referral and Consultation ; Surveys and Questionnaires
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Hearing and Vision Screening Program for newborns in Italy.
Autorzy :: Bubbico L; ENT Specialist INAPP /Italian Institute of Social Medicine, Department of Sensorineural Disabilities Research, Rome, Italy.
Ferlito S; University of Catania School of Medicine, Department of Surgical medical sciences and advanced technologies, Catania, Italy.
Antonelli G; University of Verona, Department of Neurosciences, Biomedicine and Movement Sciences, Verona, Italy.
Martini A; University of Padua, Department of Neurosciences, Padua, Italy.
Pescosolido N; University of Rome Sapienza, Department of Ophthalmology, Rome, Italy.; Pokaż więcej
Źródło :: Annali di igiene : medicina preventiva e di comunita [Ann Ig] 2021 Sep-Oct; Vol. 33 (5), pp. 433-442. Date of Electronic Publication: 2020 Dec 11.
Typ publikacji :: Journal Article
MeSH Terms :: Vision Screening*
Child ; Female ; Hearing ; Hearing Tests ; Humans ; Infant, Newborn ; Italy/epidemiology ; Neonatal Screening ; Pregnancy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Analysis of Static Molecular Gradients in a High-Throughput Drug Screening Microfluidic Assay.
Autorzy :: Szafran RG; Department of Biochemistry, Molecular Biology and Biotechnology, Faculty of Chemistry, Wroclaw University of Science and Technology, ul. Norwida 4/6, 50-373 Wroclaw, Poland.
Wiatrak B; Department of Pharmacology, Faculty of Medicine, Wroclaw Medical University, Mikulicza-Radeckiego 2, 50-345 Wroclaw, Poland.; Pokaż więcej
Źródło :: Molecules (Basel, Switzerland) [Molecules] 2021 Oct 22; Vol. 26 (21). Date of Electronic Publication: 2021 Oct 22.
Typ publikacji :: Journal Article
MeSH Terms :: High-Throughput Screening Assays*
Microfluidic Analytical Techniques*
Models, Theoretical*
Drug Discovery/*methods
Microfluidics/*methods
Algorithms ; Antineoplastic Agents/pharmacology ; Cell Culture Techniques ; Drug Evaluation, Preclinical/instrumentation ; Drug Evaluation, Preclinical/methods ; Drug Screening Assays, Antitumor ; Equipment Design ; Lab-On-A-Chip Devices ; Microfluidics/instrumentation
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 12 12.

Tytuł :: Perplexing Etiology of Hyperphenylalaninemia in an Infant Referred via Newborn Screening.
Autorzy :: Çıkı K; Division of Pediatric Metabolism, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Akar HT; Division of Pediatric Metabolism, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Özgül RK; Department of Pediatric Metabolism, Institute of Child Health, Hacettepe University, Ankara, Turkey.
Gülbakan B; Department of Pediatric Metabolism, Institute of Child Health, Hacettepe University, Ankara, Turkey.
Yıldız Y; Division of Pediatric Metabolism, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.; Pokaż więcej
Źródło :: Clinical chemistry [Clin Chem] 2021 Oct 01; Vol. 67 (10), pp. 1428-1431.
Typ publikacji :: Journal Article
MeSH Terms :: Neonatal Screening*
Phenylketonurias*/diagnosis
Humans ; Infant ; Infant, Newborn ; Mass Screening
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Virtual and experimental high throughput screening of substituted hydrazones on β-Tubulin polymerization.
Autorzy :: Xavier JS; Department of Chemistry, Sathyabama Institute of Science and Technology, Chennai 600119, India.
Jayabalan K; Department of Chemistry, Sathyabama Institute of Science and Technology, Chennai 600119, India. Electronic address: .
Ragavendran V; Department of Physics, Sri Chandrasekharendra Saraswathi Viswa Mahavidyalaya, Kanchipuram 631561, India.
Manoharan MT; Department of Chemistry, Siddha Central Research Institute, Central Council for Research in Siddha, Arumbakkam, Chennai 600106, India.
Nityananda Shetty A; Department of Chemistry, National Institute of Technology Karnataka, Mangalore 575025, India.; Pokaż więcej
Źródło :: Bioorganic chemistry [Bioorg Chem] 2021 Sep; Vol. 114, pp. 105094. Date of Electronic Publication: 2021 Jun 13.
Typ publikacji :: Journal Article
MeSH Terms :: High-Throughput Screening Assays*
Antineoplastic Agents/*pharmacology
Hydrazones/*pharmacology
Tubulin/*metabolism
Tubulin Modulators/*pharmacology
Antineoplastic Agents/chemistry ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Density Functional Theory ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; Humans ; Hydrazones/chemistry ; Molecular Docking Simulation ; Molecular Structure ; Polymerization/drug effects ; Structure-Activity Relationship ; Tubulin Modulators/chemistry
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Commentary: Significance of early screening for color vision in children.
Autorzy :: Singh AK; Department of Ophthalmology, Airforce Central Medical Establishment, New Delhi, India.
Sharma V; Department of Ophthalmology, Airforce Central Medical Establishment, New Delhi, India.; Pokaż więcej
Źródło :: Indian journal of ophthalmology [Indian J Ophthalmol] 2021 Aug; Vol. 69 (8), pp. 2026.
Typ publikacji :: Journal Article
MeSH Terms :: Color Vision*
Color Vision Defects*/diagnosis
Color Vision Defects*/epidemiology
Vision Screening*
Child ; Humans ; Mass Screening
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 15 15.

Tytuł :: Identification of Novel Fused Heteroaromatics-Based MALT1 Inhibitors by High-Throughput Screening to Treat B Cell Lymphoma.
Autorzy :: Liang X; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Sun C; Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai 200043, China.; CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, 320 Yue Yang Road, Shanghai 200031, China.
Li C; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Yu H; Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai 200043, China.; CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, 320 Yue Yang Road, Shanghai 200031, China.
Wei X; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Liu X; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Bao W; Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai 200043, China.; CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, 320 Yue Yang Road, Shanghai 200031, China.
Shi Y; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Sun X; Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai 200043, China.; CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, 320 Yue Yang Road, Shanghai 200031, China.
Khamrakulov M; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Yang C; Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai 200043, China.; CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, 320 Yue Yang Road, Shanghai 200031, China.
Liu H; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China.; School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.; Pokaż więcej
Źródło :: Journal of medicinal chemistry [J Med Chem] 2021 Jul 08; Vol. 64 (13), pp. 9217-9237. Date of Electronic Publication: 2021 Jun 28.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: High-Throughput Screening Assays*
Antineoplastic Agents/*pharmacology
Enzyme Inhibitors/*pharmacology
Lymphoma, Large B-Cell, Diffuse/*drug therapy
Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein/*antagonists & inhibitors
NF-kappa B/*antagonists & inhibitors
Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/chemistry ; Apoptosis/drug effects ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; Enzyme Inhibitors/chemical synthesis ; Enzyme Inhibitors/chemistry ; Humans ; Lymphoma, Large B-Cell, Diffuse/metabolism ; Lymphoma, Large B-Cell, Diffuse/pathology ; Molecular Structure ; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein/metabolism ; NF-kappa B/metabolism ; Signal Transduction/drug effects ; Structure-Activity Relationship
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Identification of novel gankyrin binding scaffolds by high throughput virtual screening.
Autorzy :: Kanabar D; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.
Kabir A; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.
Chavan T; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.
Kong J; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.
Yoganathan S; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.
Muth A; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA. Electronic address: .; Pokaż więcej
Źródło :: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2021 Jul 01; Vol. 43, pp. 128043. Date of Electronic Publication: 2021 Apr 16.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: High-Throughput Screening Assays*
Antineoplastic Agents/*pharmacology
Benzenesulfonates/*pharmacology
Proto-Oncogene Proteins/*antagonists & inhibitors
Small Molecule Libraries/*pharmacology
Triazoles/*pharmacology
Antineoplastic Agents/chemistry ; Benzenesulfonates/chemistry ; Binding Sites/drug effects ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Dose-Response Relationship, Drug ; Drug Evaluation, Preclinical ; Drug Screening Assays, Antitumor ; Humans ; Molecular Structure ; Proteasome Endopeptidase Complex/metabolism ; Proto-Oncogene Proteins/metabolism ; Small Molecule Libraries/chemistry ; Structure-Activity Relationship ; Triazoles/chemistry
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Universal newborn genetic screening for pediatric cancer predisposition syndromes: model-based insights.
Autorzy :: Yeh JM; Harvard Medical School, Boston, MA, USA. .; Boston Children's Hospital, Boston, MA, USA. .
Stout NK; Harvard Medical School, Boston, MA, USA.; Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Chaudhry A; Boston Children's Hospital, Boston, MA, USA.
Christensen KD; Harvard Medical School, Boston, MA, USA.; Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Gooch M; Harvard Pilgrim Health Care Institute, Boston, MA, USA.
McMahon PM; Harvard Pilgrim Health Care Institute, Boston, MA, USA.
O'Brien G; Boston Children's Hospital, Boston, MA, USA.
Rehman N; Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Blout Zawatsky CL; Brigham and Women's Hospital and Broad Institute, Boston, MA, USA.
Green RC; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital and Broad Institute, Boston, MA, USA.
Lu CY; Harvard Medical School, Boston, MA, USA.; Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Rehm HL; Harvard Medical School, Boston, MA, USA.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Williams MS; Genomic Medicine Institute, Geisinger, Danville, PA, USA.
Diller L; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.
Wu AC; Harvard Medical School, Boston, MA, USA.; Harvard Pilgrim Health Care Institute, Boston, MA, USA.; Pokaż więcej
Źródło :: Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2021 Jul; Vol. 23 (7), pp. 1366-1371. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :: Neonatal Screening*
Neoplasms*/diagnosis
Neoplasms*/genetics
Adult ; Child ; Cost-Benefit Analysis ; DEAD-box RNA Helicases ; Early Detection of Cancer ; Genetic Testing ; Humans ; Infant, Newborn ; Mass Screening ; Ribonuclease III ; Syndrome ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: The Impact of Pass/Refer Criteria in the Use of Otoacoustic Emission Technology for Newborn Hearing Screening.
Autorzy :: Kanji A; Department of Speech Pathology and Audiology, School of Human and Community Development, University of the Witwatersrand, Johannesburg, South Africa.
Naudé A; Centre for Augmentative and Alternative Communication, Faculty of Humanities, University of Pretoria, South Africa.; Pokaż więcej
Źródło :: American journal of audiology [Am J Audiol] 2021 Jun 14; Vol. 30 (2), pp. 416-422. Date of Electronic Publication: 2021 May 17.
Typ publikacji :: Journal Article
MeSH Terms :: Mass Screening*
Otoacoustic Emissions, Spontaneous*
Humans ; Infant, Newborn ; Neonatal Screening ; Referral and Consultation ; Sensitivity and Specificity ; Technology
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 19 19.

Tytuł :: Economic evaluation of population-based type 2 diabetes mellitus screening at different healthcare settings in Vietnam.
Autorzy :: Toi PL; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.; Health Strategy and Policy Institute, Ministry of Health, Hanoi, Vietnam.
Wu O; Health Economics and Health Technology Assessment (HEHTA), Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
Thavorncharoensap M; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.; Faculty of Pharmacy, Social and Administrative Pharmacy Division, Department of Pharmacy, Mahidol University, Bangkok, Thailand.
Srinonprasert V; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.; Faculty of Medicine Siriraj Hospital, Health Policy Unit, Mahidol University, Bangkok, Thailand.
Anothaisintawee T; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.; Faculty of Medicine Ramathibodi Hospital, Department of Family Medicine, Mahidol University, Bangkok, Thailand.
Thakkinstian A; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.; Faculty of Medicine Ramathibodi Hospital, Department of Clinical Epidemiology and Biostatistics, Mahidol University, Bangkok, Thailand.
Phuong NK; Health Strategy and Policy Institute, Ministry of Health, Hanoi, Vietnam.
Chaikledkaew U; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.; Faculty of Pharmacy, Social and Administrative Pharmacy Division, Department of Pharmacy, Mahidol University, Bangkok, Thailand.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2021 Dec 23; Vol. 16 (12), pp. e0261231. Date of Electronic Publication: 2021 Dec 23 (Print Publication: 2021).
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Diabetes Mellitus, Type 2/*diagnosis
Diagnostic Screening Programs/*economics
Community Health Centers/economics ; Cost-Benefit Analysis ; Delivery of Health Care ; Diabetes Mellitus, Type 2/economics ; Hospitals, District/economics ; Humans ; Hypoglycemic Agents/economics ; Mass Screening/economics ; Quality-Adjusted Life Years ; Vietnam/epidemiology
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 20 20.

Tytuł :: A method for campus-wide SARS-CoV-2 surveillance at a large public university.
Autorzy :: Chang T; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Center for Molecular Biology of RNA, University of California Santa Cruz, Santa Cruz, California, United States of America.
Draper JM; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Center for Molecular Biology of RNA, University of California Santa Cruz, Santa Cruz, California, United States of America.; Department of Molecular, Cellular and Developmental Biology, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, California, United States of America.
Van den Bout A; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Center for Molecular Biology of RNA, University of California Santa Cruz, Santa Cruz, California, United States of America.; Department of Molecular, Cellular and Developmental Biology, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, California, United States of America.
Kephart E; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Center for Molecular Biology of RNA, University of California Santa Cruz, Santa Cruz, California, United States of America.; Department of Molecular, Cellular and Developmental Biology, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, California, United States of America.
Maul-Newby H; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Center for Molecular Biology of RNA, University of California Santa Cruz, Santa Cruz, California, United States of America.; Department of Molecular, Cellular and Developmental Biology, University of California Santa Cruz, Santa Cruz, California, United States of America.
Vasquez Y; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Center for Molecular Biology of RNA, University of California Santa Cruz, Santa Cruz, California, United States of America.; Department of Molecular, Cellular and Developmental Biology, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, California, United States of America.
Woodbury J; Thirdwave Analytics, San Francisco, California, United States of America.
Randi S; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, California, United States of America.
Pedersen M; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, California, United States of America.
Nave M; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, California, United States of America.
La S; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, California, United States of America.
Gallagher N; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, California, United States of America.
McCabe MM; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; Department of Molecular, Cellular and Developmental Biology, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, California, United States of America.
Dhillon N; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; Department of Molecular, Cellular and Developmental Biology, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, California, United States of America.
Bjork I; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, California, United States of America.
Luttrell M; Business and Accounting Services, University of California Santa Cruz, Santa Cruz, California, United States of America.
Dang F; University of California Davis, Davis, California, United States of America.
MacMillan JB; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California, United States of America.
Green R; University of California Davis, Davis, California, United States of America.
Miller E; Student Health Services, University of California Santa Cruz, Santa Cruz, California, United States of America.
Kilpatrick AM; Department of Ecology and Evolutionary Biology, University of California Santa Cruz, Santa Cruz, California, United States of America.
Vaske O; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Center for Molecular Biology of RNA, University of California Santa Cruz, Santa Cruz, California, United States of America.; Department of Molecular, Cellular and Developmental Biology, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, California, United States of America.
Stone MD; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Center for Molecular Biology of RNA, University of California Santa Cruz, Santa Cruz, California, United States of America.
Sanford JR; Colligan Clinical Diagnostic Laboratory, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Center for Molecular Biology of RNA, University of California Santa Cruz, Santa Cruz, California, United States of America.; Department of Molecular, Cellular and Developmental Biology, University of California Santa Cruz, Santa Cruz, California, United States of America.; UC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, California, United States of America.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2021 Dec 17; Vol. 16 (12), pp. e0261230. Date of Electronic Publication: 2021 Dec 17 (Print Publication: 2021).
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: COVID-19/*diagnosis
COVID-19 Nucleic Acid Testing/*methods
Clinical Laboratory Techniques/*methods
Diagnostic Tests, Routine/*methods
Mass Screening/*methods
Pandemics/*prevention & control
Diagnostic Screening Programs ; Humans ; Universities
: Czasopismo naukowe

Szczegóły Pełny tekst

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""screening"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język